Factors influencing local failure in rectal cancer: Analysis of 2315 patients from a population-based series

Diseases of the Colon and Rectum

Volumn 53, Issue 5, 2010, Pages 744-752

  Syk, E ^a,b   Glimelius, B ^b,c   Nilsson, P J ^b,d  

^a ERSTA HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Local failure; Rectal cancer; Risk factor

Indexed keywords

ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; POPULATION RESEARCH; PREOPERATIVE RADIOTHERAPY; PROGNOSIS; RECTUM CANCER; RECTUM RESECTION; RISK FACTOR; SEX DIFFERENCE; SWEDEN; TREATMENT FAILURE; TUMOR LOCALIZATION; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; LYMPH NODE METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECTUM TUMOR; STATISTICAL MODEL;

AGE FACTORS; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; RISK FACTORS; SEX FACTORS; SWEDEN; TREATMENT FAILURE;

EID: 77951906327     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181cf8841     Document Type: Article

References (43)

1. Hansen MH, Kjaeve J, Revhaug A, et al. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg. 2007;94:113-118.
2. Pahlman L, Bohe M, Cedermark B, et al. The Swedish rectal cancer registry. Br J Surg. 2007;94:1285-1292.
3. Martling AL, Holm T, Rutqvist LE, et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356:93-96.
4. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8, 507 patients from 22 randomised trials. Lancet. 2001;358:1291-1304.
5. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646.
6. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med. 1997;336:980-987.
7. Sebag-Montefiore D, Steele R, Quirke P, et al. Routine short course pre-op radiotherapy or selective post-op chemoradio- therapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. ASCO Meeting Abstracts. J Clin Oncol. 2006:24 (148 S): Abstr 3511.
8. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Late adverse effects of radiation therapy for rectal cancer: a systematic overview. Acta Oncol. 2007;46:504-516.
9. Bullard KM, Trudel JL, Baxter NN, Rothenberger DA. Primary perineal wound closure after preoperative radiotherapy and abdominoperineal resection has a high incidence of wound failure. Dis Colon Rectum. 2005;48:438-443.
10. Peeters KC, van de Velde CJ, Leer JW, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients: a Dutch colorectal cancer group study. J Clin Oncol. 2005;23:6199-6206.
11. Pollack J, Holm T, Cedermark B, et al. Long-term effect of pre- operative radiation therapy on anorectal function. Dis Colon Rectum. 2006;49:345-352.
12. Dahlberg M, Glimelius B, Graf W, Pahlman L. Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum. 1998;41:543-551.
13. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Adverse effects of preoperative radiation therapy for rectal cancer: long- term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol. 2005;23:8697-8705.
14. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg. 2008;95:206-213.
15. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Occur- rence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol. 2005;23:6126-6131.
16. Wibe A, Eriksen MT, Syse A, et al. Total mesorectal excision for rectal cancer: what can be achieved by a national audit? Colorectal Dis. 2003;5:471-477.
17. Martling A, Cedermark B, Johansson H, et al. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg. 2002;89:1008-1013.
18. Glimelius B. Rectal cancer irradiation: long course, short course or something else? Acta Oncol. 2006;45:1013-1017.
19. Braendengen M, Tveit KM, Berglund A, et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol. 2008;26:3687-3694.
20. Syk E, Torkzad MR, Blomqvist L, et al. Local recurrence in rectal cancer: anatomic localization and effect on radiation target. Int J Radiat Oncol Biol Phys. 2008;72:658-664.
21. Sobin LH, Wittekind C. UICC International Union Against Cancer: TNM Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002.
22. Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma: experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori. 1995;81(3 suppl): 60-64.
23. den Dulk M, Marijnen CA, Putter H, et al. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg. 2007;246:83-90.
24. Manfredi S, Benhamiche AM, Meny B, et al. Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer. Br J Surg. 2001;88:1221-1227.
25. Graf W, Dahlberg M, Osman MM, et al. Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients. Radiother Oncol. 1997;43:133-137.
26. Martling A, Granath F, Cedermark B, Johansson R, Holm T. Gender differences in the treatment of rectal cancer: a population based study. Eur J Surg Oncol. 2009;35:427-433.
27. Holm T, Johansson H, Cedermark B, et al. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg. 1997;84:657-663.
28. McArdle CS, Hole DJ. Influence of volume and specialization on survival following surgery for colorectal cancer. Br J Surg. 2004;91:610-617.
29. Schrag D, Panageas KS, Riedel E, et al. Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg. 2002;236:583-592.
30. Long RT, Edwards RH. Implantation metastasis as a cause of local recurrence of colorectal carcinoma. Am J Surg. 1989;157:194-201.
31. Constantinides VA, Cheetham D, Nicholls RJ, Tekkis PP. Is rectal washout effective for preventing localized recurrence after anterior resection for rectal cancer? Dis Colon Rectum. 2008;51:1339-1344.
32. Smith FM, Reynolds JV, Miller N, et al. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. Eur J Surg Oncol. 2006;32:55-64.
33. Ueno H, Mochizuki H, Hashiguchi Y, et al. Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer. Ann Surg. 2004;239:34-42.
34. Holm T, Ljung A, Haggmark T, et al. Extended abdominoperi- neal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg. 2007;94:232-238.
35. den Dulk M, Putter H, Collette L, et al. The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer. 2009;45:1175-1183.
36. Marr R, Birbeck K, Garvican J, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242:74-82.
37. Daniels IR, Fisher SE, Heald RJ, Moran BJ. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence. Colorectal Dis. 2007;9:290-301.
38. Bipat S, Glas AS, Slors FJ, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology. 2004;232:773-783.
39. Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors-the circumferential resection margin and nodal disease-of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR. 2005;26:259-268.
40. Koh DM, Brown G, Husband JE. Nodal staging in rectal cancer. Abdom Imaging. 2006;31:652-659.
41. Dworak O. Morphology of lymph nodes in the resected rectum of patients with rectal carcinoma. Pathol Res Pract. 1991;187:1020-1024.
42. Smith N, Brown G. Preoperative staging of rectal cancer. Acta Oncol. 2008;47:20-31.
43. Valentini V, Glimelius B, Minsky BD, et al. The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus. Radiother Oncol. 2005;76:241-250.